Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FCH PET for Parathyroid Lesion Localization
NCT03555487Phase 3Completed
- Sponsor
- National Taiwan University Hospital
- Start
- May 2015
- Primary completion
- Jun 2018
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 3 trial of fluorine-18 fluorocholine in hyperparathyroidism, sponsored by National Taiwan University Hospital. Started May 2015; status: completed.
02
Drugs
fluorine-18 fluorocholine
03
Conditions
hyperparathyroidism
Beyond the preview
Go deeper on NCT03555487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03555487.